Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization.
Zeynep Yegin Katranİsmet BulutAylin BabalikMetin KerenPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)
Our study is the largest series of patients who developed type 1 immediate hypersensitivity reaction while receiving antituberculosis treatment. A practical, easy desensitization scheme has been shared.